MAb VRC07-523LS
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MAb VRC07-523LS, covering 2020-12-30 to 2020-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy Adults [Phase 1]